Observation and nursing of adverse reactions in chronic myelocytic leukemia patients receiving imatinib therapy
10.3760/cma.j.issn.1672-7088.2013.19.016
- VernacularTitle:伊马替尼治疗慢性髓细胞性白血病不良反应的观察及护理
- Author:
Ling LU
;
Sufang ZHAO
;
Ri ZHANG
- Publication Type:Journal Article
- Keywords:
Imatinib;
Chronic myelocytic leukemia;
Adverse reactions;
Nursing care
- From:
Chinese Journal of Practical Nursing
2013;29(19):33-35
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the observation and nursing of adverse reactions in chronic myelocytic leukemia patients receiving imatinib therapy.Methods Adverse reactions were observed and recorded in 193 chronic phase myelocytic leukemia patients who received imatinib therapy,and corresponding treatment and nursing were given to them.Results Among 193 patients,more than 60％ of patients had adverse reactions,of which,54％ of patients showed gastrointestinal adverse reactions including nausea,vomiting,anepithymia and diarrhea; 22％ of them had muscle and bone pain; 7％ had rash; 65％ got edema.After proper treatment and nursing,all adverse effects obtained satisfactory remission.Condusions During the treatment course of chronic myelocytic leukemia patients using imatinib,careful observation of any possible adverse reactions,and giving corresponding treatment and nursing can facilitate good compliance and longterm remission of patients.
